New York-based Healthcare communications network inVentiv Health Communications has completed its merger with Raleigh, NC-based global contract research organization INC Research.
The merger, which was first announced earlier this year, brings together a collective of agencies spanning the public relations, advertising and strategic solutions sectors including PR firms Allidura Consumer, Biosector 2, Chamberlain Healthcare PR and Chandler Chicco Agency, as well as branding and advertising agencies such as Addison Whitney, GSW, PALIO and The Navicor Group.
The merger bills itself as the only fully integrated biopharmaceutical solutions organization to include an end-to-end CRO and COO, and effectively creates the second-largest biopharmaceutical outsourcing provider and the largest contract commercial organization by revenue, with combined net revenue at more than $3 billion.
The combined entity will be known as INC Research/inVentiv Health on an interim basis, with a brand relaunch expected to occur in January.
Its leadership team will consist of chief executive officer Alistair Macdonald (previously CEO of INC Research) chief financial officer Greg Rush (previously executive VP and CFO of INC Research) and board of directors executive chairman and commercial division president Michael Bell (formerly CEO of inVentiv).
“By coming together with INC Research, we’ll be able to infuse our best-in-class communications solutions earlier into the clinical development process,” Bell told O’Dwyer’s. “One example is our ability to leverage our communications and behavioral analysis expertise to streamline the clinical trial recruitment process. We’re able to reach the right patients quickly and communicate with them effectively, speeding up trial enrollment and the eventual delivery of therapies to those that need them the most.”